Add BrightSurf on Google Email

Immune cell receptor and ligand regulation: A therapeutic avenue for inflammatory diseases

A study by Tokyo University of Science researchers identifies a novel regulatory axis targeting dendritic cell activity, suppressing autoimmune disease symptoms and bone loss. They discovered DCIR binds to glycoproteins on macrophages and osteoclasts, reducing inflammation and immune responses.

SourceTokyo University of Science·JournalJournal of Experimental Medicine·TypeExperimental study·DateNov 24, 2021

Treatment with gene therapy of a new rat model of Morquio A, a disease with severe skeletal dysplasia and cartilage deterioration

Researchers at Universitat Autonoma de Barcelona develop gene therapy that fully corrects severe whole-body alterations in Morquio A disease, a rare condition caused by GALNS enzyme deficiency. The therapy, administered via intravenous viral vector, prevents bone malformations and life-threatening complications.

SourceUniversitat Autonoma de Barcelona·JournalNature Communications·TypeExperimental study·DateSep 10, 2021

Researchers from the IDIBELL and the University of Barcelona describe a new treatment that could cope with 2 bone diseases

Researchers have described a new treatment that could cope with Heterotopic Ossification and Fibrodysplasia Ossificans Progressiva using a PI3-kinase inhibitor. The study shows promising results in preclinical models, potentially leading to improved treatment options for patients.

SourceIDIBELL-Bellvitge Biomedical Research Institute·JournalEMBO Molecular Medicine·DateAug 2, 2019

Solution to medical mystery may help some children avoid bone marrow transplantation

A study by St. Jude Children's Research Hospital and UCSF identified germline mutations in the genes SAMD9 or SAMD9L as responsible for a rare bone marrow disorder, myelodysplasia and leukemia syndrome with monosomy 7. The research found that some children with these mutations can spontaneously recover normal bone marrow function witho...

Arthritis on the rise

A recent Harvard University study reveals that knee osteoarthritis has dramatically increased in prevalence over the past 70 years, affecting an estimated one-third of Americans over 60. The research challenges the long-held assumption that osteoarthritis is simply a wear-and-tear disease related to aging and obesity.

SourceHarvard University·JournalProceedings of the National Academy of Sciences·DateAug 14, 2017

Measurement helps craniofacial surgeons better evaluate children with skull deformity

A new method of evaluation, using the cephalic width-intercoronal distance ratio, has been recommended to help determine when surgical intervention is needed for infants with fused cranial sutures. This measurement indicates a potential need for surgery in cases where the front and back of the skull are not proportionate.

SourceUniversity of Missouri-Columbia·JournalThe Cleft Palate-Craniofacial Journal·DateOct 4, 2016

Exposure to inflammatory bowel disease drugs could increase leukemia risk

A new study published in Clinical Gastroenterology and Hepatology found that thiopurine therapy for inflammatory bowel disease (IBD) may increase the risk of myeloid disorders, including acute myeloid leukemia. The study analyzed data from over 19,000 IBD patients and found a seven-fold increased risk among those taking thiopurines.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateAug 6, 2014

New treatment for brittle bone disease found

Researchers at the University of Sheffield have developed a new treatment for children with brittle bone disease, finding that oral risedronate significantly reduces the risk of fractures. The study showed rapid action, with curves for fracture risk diverging after just 6 weeks of treatment.

SourceUniversity of Sheffield·JournalThe Lancet·DateAug 9, 2013